Promis NeurosciencesPMN
13F holders, Q4 2024 (December 31)17holders −1
0new positions
2sold out
$0.95avg. 13F price*
At the end of Q4 2024, 17 institutions reported holding Promis Neurosciences Inc. (PMN) in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 2 sold out. The largest holders were Great Point Partners LLC ($2.5M), Armistice Capital, LLC ($2.4M) and Sphera Funds Management LTD. ($1.8M).
- Company
- Promis Neurosciences Inc.
- CUSIP
- 74346M406
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $38K |
All 13F filers, Q3 2024 → Q4 2024: 4,741 shares bought and 569,684 shares sold, net −564,943 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Great Point Partners LLC | 1.18% | Reduce -5.2% | 2,645,128 | $2.5M |
| Armistice Capital, LLC | 0.06% | Reduce -6.0% | 2,509,977 | $2.4M |
| Sphera Funds Management LTD. | 0.34% | No change | 1,929,297 | $1.8M |
| Ally Bridge Group (NY) LLC | 1.29% | No change | 1,592,605 | $1.5M |
| Altium Capital Management LLC | 0.17% | No change | 581,395 | $551K |
| Allostery Investments LP | 0.36% | — | 195,111 | $185K |
| Heights Capital Management, Inc. | 0.08% | Reduce -58.6% | 160,207 | $152K |
| Bank of Montreal | 0.00% | No change | 30,366 | $29K |
| Ieq Capital, LLC | 0.00% | No change | 26,042 | $25K |
| Fiduciary Trust Co | 0.00% | Reduce -32.1% | 13,583 | $13K |
| Scotia Capital Inc. | 0.00% | No change | 12,122 | $11K |
| Claret Asset Management Corp | 0.00% | No change | 11,330 | $11K |
| Royal Bank of Canada | 0.00% | Add +635.5% | 5,487 | $5K |
| Sandy Spring Bank | 0.00% | No change | 3,300 | $3K |
| Bank of America Corp. | 0.00% | No change | 1,666 | $2K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 133 | $126 |
| National Bank of Canada | 0.00% | Reduce -79.1% | 88 | $83 |
"% of holder's portfolio" is PMN's weight in each manager's 13F, not the share of Promis Neurosciences Inc. the manager owns.